NCT06246149 2026-03-04ATOMEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 3 Recruiting290 enrolled
NCT06070012 2026-02-27Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal MelanomaUniversity of PittsburghPhase 2 Recruiting44 enrolled
NCT05549297 2026-02-25Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)Immunocore LtdPhase 3 Recruiting540 enrolled